News By Tag Industry News News By Place Country(s) Industry News
| ![]() Cell Encapsulation: Focus on Therapeutics and Technologies, 2019-2030Roots Analysis has done a detailed study on Cell Encapsulation: Focus on Therapeutics and Technologies, 2019-2030, covering key aspects of the industry's evolution and identifying potential future growth opportunities.
By: Roots Analysis The USD 3.7 billion (by 2030) financial opportunity within the encapsulated cell therapies and encapsulation technologies market has been analyzed across the following segments: § Type of licensing deal payment § Upfront payment § Milestone payment § Therapeutic area § Metabolic disorder § Neurological disorder § Ophthalmic disorder § Oncological disorder § Target disease indication § Ataxia telangiectasia § Breast cancer § Diabetes § Glaucoma § Head and neck cancer § Macular telangectasia § Pancreatic cancer § Parkinson's disease § Retinitis pigmentosa § Type of encapsulation material used § Alginate-based microcapsule § Cellulose hydrogel § Medical-grade plastic § Red blood cell § Key geographical region § North America § Europe § Asia-Pacific and rest of the world The Cell Encapsulation: § ALTuCELL § Azellon Cell Therapeutics § Beta-Cell § Betalin Therapeutics § CellProtect Biotechnology § Diatranz Otsuka § Encellin § EryDel Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Current Market Landscape 5. Encapsulated Cell Therapies and Encapsulation Technologies for Metabolic Disorders: Company Profiles 6. Encapsulated Cell Therapies and Encapsulation Technologies for Non-Metabolic Disorders: Company Profiles 7. Patent Analysis 8. Clinical Trial Analysis 9. Recent Partnerships 10. Funding and Investment Analysis 11. Grant Analysis 12. Potential Strategic Partners 13. Market Forecast 14. Conclusion 15. Executive Insights 16. Appendix 1: Tabulated Data 17. Appendix 2: List of Companies and Organizations To purchase a copy, please visit https://rootsanalysis.com/ Contact: Gaurav Chaudhary +1 (415) 800 3415 +44 (122) 391 1091 Gaurav.Chaudhary@ End
|
|